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Bovine pericardial patch repair in infected fields
William D. McMillan, MD, Christopher D. Leville, MD, and Chantel N. Hile, MD, Plymouth, Minn
Objective: Bovine pericardial patches (BPP) are frequently used for arterial reconstruction, but little data exist regarding
their ability to resist infection. We hypothesize that BPP would provide a reasonable alternative to autologous vein
patches in infected fields.
Methods: We used BPP to repair 51 arteriotomies (25 brachial, 23 femoral, three popliteal) in 48 consecutive patients
(mean age, 68 years; 65% men, 75% diabetic, 67% dialysis dependent) undergoing removal of infected (33 gram-positive,
three gram-negative, eight mixed flora, and four culture-negative) polytetrafluoroethylene grafts (35 arteriovenous
grafts, nine femoral-distal bypasses, and four femoral patch angioplasties) between January 2007 and January 2011.
Patient records were retrospectively reviewed and outcomes, including death, rupture, secondary reconstruction, and
infection, were recorded.
Results: Over a mean follow-up of 2.1 years (range, 3-48 months), 50 of 51 patches remained in place without evidence
of recurrent infection, rupture, or revision. One patient had acute rupture of a popliteal arteriotomy 1 week postrepair
and had subsequent ligation and above-knee amputation. Eight of the 48 patients died from unrelated causes during
follow-up (three withdrew from dialysis, three myocardial infarction, and two unknown).
Conclusions: BPP provide a durable alternative to saphenous vein for arterial reconstruction following removal of infected
arterial grafts. ( J Vasc Surg 2012;55:1712-5.)
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dProsthetic graft infection remains a challenge for the
practicing vascular surgeon. Major graft infection requiring
excision occurs infrequently after lower extremity bypass,
with an estimated frequency of 1% to 2%. Infections in
arteriovenous (AV) dialysis access grafts are more common,
occurring in 3% to 8% of patients.1-7 Regardless of location,
graft infection is associated with significant mortality and
morbidity.
Nearly all such infections mandate removal of the
infected graft. While multiple treatment algorithms ex-
ist, most involve resection of the infected graft and
closure of the resulting arteriotomies. To accomplish
this, some authors employ in situ replacement.8,9 Others
favor subtotal graft excision and leave a stump of graft
remaining on the artery.10,11 Most, however, choose
total graft excision and closure of the arterial defect using
autologous material.3-5,12
Bovine pericardial patches (BPP) are frequently used
for arterial closure, and numerous publications detail ac-
ceptable long-term patency and durability when used as
patch material for carotid endarterectomy.13-18,21,22 The
same material has also been used with some success during
reconstruction of infected bronchial stumps and occasion-
ally for intracardiac infection. However, data regarding the
effectiveness of BPP in infected fields are limited to isolated
case reports and no long-term data are available.19,20,23,24
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1712We review our experience using BPP to repair arterioto-
ies in patients undergoing total graft excision for infection.
ETHODS
Between January 1, 2007 and January 1, 2011, 48
onsecutive patients presenting with prosthetic graft infec-
ion had total graft excision and BPP closure of 51 arteri-
tomies. During this same interval, we placed 730 AV
stulae, 590 AV grafts, 518 lower extremity bypasses, and
id 430 femoral endarterectomies. Of the patients treated
or infection, 32 of 48 (26 AV grafts, four lower extremity
ypasses, and two femoral endarterectomies) had graft
lacement by our group, and the remaining patients were
eferred with infection for treatment.
All patients undergoing graft excision had arterial clo-
ure using a portion of a 0.8-cm  8-cm BPP (Synovis
edical, St. Paul, Minn). No other type of patch material
as used during the interval. During the same interval,
any dialysis patients presented with localized graft infec-
ions secondary to access site infection, and these were
andled by localized excision and replacement and are not
art of the current study. However, no patient in the
urrent series underwent subtotal graft excision using a
mall portion of polytetrafluoroethylene (PTFE) remaining
s a stump closure of the arteriotomy.
All upper extremity graft excisions were done with
ourniquet control. This technique provided adequate ar-
erial exposure for closure and obviated the need for dissec-
ion around the inflamed brachial artery. Of the 25 cases,
our had simultaneous construction of a new upper extrem-
ty AV fistula. Lower extremity graft excisions were accom-
lished using standard vascular surgical techniques. All
emoral venotomies in the 10 lower extremity AV graft
atients were repaired primarily. Of the nine patients un-
ergoing removal of an arterial femoral distal arterial graft,
ve had removal with extra-atomic bypass (three of five had
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Volume 55, Number 6 McMillan et al 1713closure of the femoral and popliteal artery, two of five had
oversewing of the distal artery and closure of the femoral
only), and four had removal with subsequent planned
major amputation. All four of the patients presenting with
infected femoral patches had complete excision of the old
patch and replacement using BPP.
The majority (35 of 48) of patients undergoing BPP
arterial closure had their skin left open and were allowed to
heal by secondary intention. All patients undergoing re-
moval of a femoral graft had a Sartorius muscle flap placed
at the time of removal. In the patients with infected upper
arm grafts, the skin was left open only if there was extensive
purulence. Attempts were always made to place soft tissue
across the artery to prevent late rupture. Thirteen of 25
patients undergoing upper extremity graft removal had
primary skin closure.
All patients undergoing removal were treated with
intravenous antibiotics postoperatively. Most (83%) were
treated for 4 weeks or more, although 16% switched to oral
antibiotics after 2 weeks of intravenous therapy.
All patients were followed retrospectively using a com-
bination of medical record review and direct patient con-
tact. Outcomes, including death, rupture, amputation, sec-
ondary infection, and/or reconstruction, were recorded.
RESULTS
The mean age of the 48 patients presenting with infec-
tion requiring total graft excision was 68 years (range,
48-81 years), and 75% of these patients were diabetic.
Sixty-five percent were men, 73% had chronic renal failure,
and 67% were dialysis dependent at the time of removal.
All patients in this series had total graft excision and
were thought to have involvement of the entire graft
and/or the arterial anastomosis. During the same interval,
other patients, not included in the present series, presented
with localized infections amenable to local resection/re-
placement or antibiotic therapy alone. The most common
presentation of patients in the current series was that of
erythema, pain, and fever occurring in 32 (67%) patients.
The remaining patients presented with positive blood cul-
tures and fever in 11 (23%), exposed graft with drainage in
four (8%), and arterial pseudoaneurysm in one (2%). The
vast majority (45 of 48) of patients were imaged with
computed tomography or ultrasound prior to graft removal
and were found to have changes consistent with infection.
Approximately half (25 of 48) of the patients had
Table I. Patch location and outcome
Infected graft Patients/patches
Arteriovenous graft 35/35 35/
re
Lower extremity bypass 9/12 1/1
Femoral endarterectomy 4/4 4/4
reremoval of infected PTFE upper extremity AV grafts with Dimultaneous closure of the brachial artery. Ten patients
resented with infected femoral AV grafts and had femoral
rtery BPP closure. Nine patients presented with infected
ower extremity PTFE arterial grafts, and four had removal
nd in situ replacement of infected Dacron femoral artery
atch angioplasties (Table I).
Cultures were obtained in all patients undergoing graft
emoval. Gram-positive organisms were identified in 33 of
8 patients, mixed flora in eight of 48 patients, gram-
egative in three of 48 patients, and no growth was found
n the remaining four patients (Table II). The most com-
on cultured organisms were Staphylococcus aureus (19 of
1; 37%) and Streptococcus group B (seven of 51; 14%).
mong the gram-negative organisms identified, Pseudomo-
as aeruginosa, E coli, and Salmonella were each identified
n two patients (Table III).
Patients were followed clinically until they had achieved
omplete wound healing. Subsequent follow-up consisted
f retrospective chart review and direct patient phone calls.
n addition, dialysis patients were followed by contacting
heir dialysis units and referring nephrologists. Follow-up
as available for all 48 patients.
Mean follow-up was 2.1 years (range, 3-48 months).
utcome patch Long-term follow-up
o late rupture or local
nce
6/35 died–none due to infection;
31/35 had new access placed
ed (rupture) 2/9 died–neither due to
infection
4/9 had amputation
upture or local
nce
No deaths/amputations
able II. Culture results
No. patients
(%)
ram-positive 33/48 (69%)
ixed flora 8/48 (17%)
ram-negative 3/48 (6%)
o growth 4/48 (8%)
able III. Organisms
ost frequently cultured organisms
Percentage of all
organisms
cultured
taphylococcus aureus (MRSA) 22%
taphylococcus aureus (MSSA) 16%
treptococcus group B 14%
seudomonas aeruginosa 4%
coli 4%
almonella 4%O
35 n
curre
2 fail
no ruring follow-up of the 51 pericardial patches placed, only
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This occurred in a patient undergoing removal of an in-
fected femoral to below-the-knee popliteal bypass. One
week after graft excision and BPP angioplasty of the femo-
ral and popliteal arteries, the patient suffered disruption of
the popliteal patch and hemorrhage. Cultures subsequently
grew methicillin-resistant Staphylococcus aureus. He under-
went ligation of the popliteal artery and subsequent above-
the-knee amputation. His femoral patch remains in place
and without evidence of infection 22 months postgraft
excision.
During follow-up, eight patients died. Three of the
patients withdrew from dialysis, two had cardiovascular
events, and two died from an unknown cause. No patient
developed recurrent infection at the site of arterial repair.
No patient had subsequent reoperation, repair, or replace-
ment of the patched arterial segment.
Of the 35 patients undergoing AV graft excision, 31
had a subsequent AV access placed. Four patients were
dialized via catheters without subsequent AV access place-
ment. None of the 31 patients who had a new AV access
placed developed recurrent infections during follow-up. All
10 of the patients undergoing removal of a femoral arterial
AV graft had a Sartorious flap placed at the time of graft
excision.
Of the nine patients undergoing removal of a lower
extremity bypass, five ultimately had ipsilateral major am-
putation during follow-up. Three of these patients were
initially treated without bypass replacement and underwent
staged major amputation. Two additional patients had
extra-anatomic bypass with laterally tunneled spliced vein,
which failed after 16 months and 19 months, respectively,
and ultimately led to ipsilateral amputation. Four had suc-
cessful extra-anatomic bypass and achieved long-term limb
salvage. Three had a laterally tunneled PTFE graft placed
from the profunda femoris artery to a tibial vessel, and one
had a laterally tunneled cadaveric vein graft from the fem-
oral patch to the anterior tibial artery. None of the nine had
to have replacement or revision of the femoral pericardial
patch.
Finally, all four of the patients presenting with infected
femoral Dacron patches had successful in situ replacement
with BPP and Sartorius flap closure.
DISCUSSION
Multiple strategies for the management of infected
arterial bypass grafts exist. Total graft excision and autoge-
nous arterial closure remains the benchmark against which
other strategies are measured.3-5,12 Bandyk and others have
popularized the concept in selective in situ graft replace-
ment when low-virulence organisms are encountered, sav-
ing total graft excision for high-virulence organisms or for
failed in situ replacement.8,9 Ryan et al and others have
advocated the selective use of prosthetic graft stump arterial
closure with subtotal graft excision in AV grafts and for
selected infections of lower extremity arterial grafts.10,11
However, the same authors advocate total graft excision
when there is frank purulence and poor incorporation. tore recently, some authors have employed stent grafts to
eal with infected arterial anastomoses in larger arter-
es.20,24 Appropriately applied, each of these strategies
eems to achieve reasonable results in published reports.
When total graft excision is required, identifying and
arvesting appropriate autogenous material for closure of
he arteriotomy can be challenging. Many patients, espe-
ially those on hemodialysis, may have limited vein avail-
ble. In addition, dissection in the infected reoperative field
an be tedious and time consuming. Finally, if a portion of
ein is identified, it is often thin or otherwise marginal in
uality so that late failure or “blowout” is of concern.
While there are several case reports of bovine pericar-
ium used for cardiac and pulmonary reconstruction in
nfected fields, there are no series or long-term follow-up
ata available.19,20,23,24 Certainly, the patch material has
roven durable in a number of arterial applications, most
ommonly as a patch material for carotid endarterecto-
y.13-18,21,22 We have used BPP for all of our elective
arotid and femoral endartectomies over the past decade.
Our adaptation of the BPP for arterial closure in in-
ected fields grew out of necessity. Our initial experience
nvolved a patient who ruptured an infected aortic stump
ollowing excision of the abdominal aorta for primary Sal-
onella aortic infection. Following reconstruction of the
erivisceral aorta using a BPP, the patient survived and is
live today without evidence of recurrent infection. Given
his initial success, we slowly adapted the use of BPP for
rterial stump closure in difficult cases and switched com-
letely in 2007.
The type and location of infections in our patients are
ypical for a busy vascular practice with AV access cases
ominating the current series. We could identify no differ-
nce in the outcomes of the patients treated based on the
nfecting organism or type of bypass excised. This likely
elates to the small numbers of patients involved and the
ariety of organisms identified. Our infection rates for AV
rafts mirror those reported elsewhere, with 26 of 590 (4%)
resenting with infection. Of the 26, 11 presented within
0 days of placement and the remaining patients presented
onths to years later. Similarly, our major infection rate for
emoral-distal bypass (four of 518;1%) and femoral endar-
erectomy (two of 430; 1%) seems comparable with other
ontemporary experiences.
The routine use of pericardial patch closure of arteriot-
mies has facilitated the operation. We find that the han-
ling characteristics of the patches are better than that of a
ein patch, and that by using an off-the-shelf product, we
void the additional time and dissection needed to identify
utogenous material for closure. We chose the 0.8-mm-
hickness patch simply because of our familiarity with it for
losure of the carotid, but these patches are noticeably
hicker than a typical vein and perhaps more resistant to late
upture. Finally, as opposed to other treatment strategies
escribed earlier, we were able to use the pericardial patches
ithout regard to the type of organism or extent of infec-
ion.
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retrospective nature makes comparison with other treat-
ment strategies problematic. For instance, it is impossible
to say whether in situ replacement with PTFE or PTFE
stump closure of the arteriotomies might have fared as well
as did the pericardial patch closure in the current series.
Direct comparison of our results to series of PTFE stump
closure10,11 or in situ replacement8 is difficult, as each of
the former techniques limits application to certain subsets
of patients. However, our freedom from infection or rup-
ture in 50 of 51 patched arteries does compare favorably to
historical reviews of autogenous patch closure, in which as
many as 3% to 5% of patients developed recurrent infection
or aneurysm.3-5 Still, critics of the current study might
justifiably point out that themajority of patients had dialysis
graft infections with lower-virulence gram-positive organ-
isms, a fact that might limit the widespread applicability of
pericardial patch closure.
There is little doubt that any number of treatment
strategies, when properly applied, allow for successful clo-
sure of an arteriotomy after excision of infected graft mate-
rial. Our experience with BPP suggests that they too pro-
vide a useful tool in the treatment of infected grafts. Unlike
other strategies, we have found them to be useful regardless
of organism, extent of graft involvement, or location of the
graft. While the retrospective nature of our study precludes
any direct comparison to the “gold standard” of autoge-
nous arterial closure, our results suggest that BPP closure is
a viable option during total graft excision for infection.
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